IMMUNO-020 HOLDINGS LIMITED

Dissolved London

Activities of other holding companies n.e.c.

Activities of other holding companies n.e.c.
I

IMMUNO-020 HOLDINGS LIMITED

Activities of other holding companies n.e.c.

Founded 12 Oct 2017 Dissolved London, United Kingdom website.com
Activities of other holding companies n.e.c.

Previous Company Names

IMMUNOVANT HOLDINGS LIMITED 12 Oct 2017 — 23 May 2018
Accounts
Confirmation Submitted 31 Oct 2022 Next due 25 Oct 2023 31 months overdue
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Full company profile for IMMUNO-020 HOLDINGS LIMITED (11009184), a dissolved company based in London, United Kingdom. Incorporated 12 Oct 2017. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 4 Shares £107k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Mar 20221$64k$64k
31 Mar 20211$495.94$495.94
31 Mar 20211$30k$30k
29 Mar 20191$13k$13k

Officers

Officers

2 active 1 resigned
Status
Mark CraigDirectorBritishUnited Kingdom525 Aug 2022Active
Vistra Cosec LimitedCorporate-secretaryUnited KingdomUnknown12 Oct 2017Active

Shareholders

Shareholders (1)

Immuno-020 Ltd.
100.0%
20,564

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Roivant Sciences Ltd.

Bermuda

Active
Notified 1 Oct 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

IMMUNO-020 HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Jun 2023GazetteGazette Dissolved Voluntary
28 Mar 2023GazetteGazette Notice Voluntary
15 Mar 2023DissolutionDissolution Application Strike Off Company
9 Mar 2023CapitalStatement by Directors
9 Mar 2023CapitalCapital Statement Capital Company With Date Currency Figure
13 Jun 2023 Gazette

Gazette Dissolved Voluntary

28 Mar 2023 Gazette

Gazette Notice Voluntary

15 Mar 2023 Dissolution

Dissolution Application Strike Off Company

9 Mar 2023 Capital

Statement by Directors

9 Mar 2023 Capital

Capital Statement Capital Company With Date Currency Figure

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

2 years ago on 13 Jun 2023

Gazette Notice Voluntary

3 years ago on 28 Mar 2023

Dissolution Application Strike Off Company

3 years ago on 15 Mar 2023

Statement by Directors

3 years ago on 9 Mar 2023

Capital Statement Capital Company With Date Currency Figure

3 years ago on 9 Mar 2023